Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT
 
 
DownloadE-Mail
 Lokale TagsFreigabegeschichteDetailsÜbersicht
  Discovery of Highly Potent p53-MDM2 Antagonists and Structural Basis for Anti-Acute Myeloid Leukemia Activities

Huang, Y., Wolf, S., Beck, B., Koehler, L.-M., Khoury, K., Popowicz, G. M., et al. (2014). Discovery of Highly Potent p53-MDM2 Antagonists and Structural Basis for Anti-Acute Myeloid Leukemia Activities. ACS CHEMICAL BIOLOGY, 9(3), 802-811. doi:10.1021/cb400728e.

Item is

 

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:
Datensatz-Permalink: https://hdl.handle.net/11858/00-001M-0000-0019-8B65-0 Versions-Permalink: https://hdl.handle.net/11858/00-001M-0000-0019-8B66-E
Genre: Zeitschriftenartikel

Externe Referenzen

einblenden:

Urheber

einblenden:
ausblenden:
 Urheber:
Huang, Yijun1, Autor
Wolf, Siglinde2, Autor           
Beck, Barbara1, Autor
Koehler, Lisa-Maria1, Autor
Khoury, Kareem1, Autor
Popowicz, Grzegorz M.2, Autor           
Goda, Sayed K.1, Autor
Subklewe, Marion1, Autor
Twarda, Aleksandra1, Autor
Holak, Tad2, Autor           
Domling, Alexander1, Autor
Affiliations:
1external, ou_persistent22              
2Holak, Tad / NMR Spectroscopy, Max Planck Institute of Biochemistry, Max Planck Society, ou_1565154              

Inhalt

einblenden:
ausblenden:
Schlagwörter: PROTEIN-PROTEIN INTERACTIONS; LEAD COMPOUNDS; CELL-LINES; P53; MDM2; NMR; INHIBITORS
 Zusammenfassung: The inhibition of p53-MDM2 interaction is a promising new approach to non-genotoxic cancer treatment. A potential application for drugs blocking the p53-MDM2 interaction is acute myeloid leukemia (AML) due to the occurrence of wild type p53 (wt p53) in the majority of patients. Although there are very promising preclinical results of several p53-MDM2 antagonists in early development, none of the compounds have yet proven the utility as a next generation anticancer agent. Herein we report the design, synthesis and optimization of YH239-EE (ethyl ester of the free carboxylic acid compound YH239), a potent p53-MDM2 antagonizing and apoptosis-inducing agent characterized by a number of leukemia cell lines as well as patient-derived AML blast samples. The structural basis of the interaction between MDM2 (the p53 receptor) and YH239 is elucidated by a co-crystal structure. YH239-EE acts as a prodrug and is the most potent compound that induces apoptosis in AML cells and patient samples. The observed superior activity compared to reference compounds provides the preclinical basis for further investigation and progression of YH239-EE.

Details

einblenden:
ausblenden:
Sprache(n): eng - English
 Datum: 2014-03
 Publikationsstatus: Erschienen
 Seiten: 10
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: -
 Identifikatoren: ISI: 000333477300028
DOI: 10.1021/cb400728e
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: ACS CHEMICAL BIOLOGY
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: 1155 16TH ST, NW, WASHINGTON, DC 20036 USA : AMER CHEMICAL SOC
Seiten: - Band / Heft: 9 (3) Artikelnummer: - Start- / Endseite: 802 - 811 Identifikator: ISSN: 1554-8929